Edwards Lifesciences Percutaneous Mitral Valve Replacement Patent B2
Summary
The USPTO granted patent US12599480B2 to Edwards Lifesciences Corporation for a percutaneous mitral valve replacement device. The prosthetic heart valve includes an outer frame with atrial flange, an inner frame, and a valve structure with leaflets, designed to match the patient's native mitral valve anatomy. The patent contains 10 claims and was filed on November 15, 2023.
What changed
The USPTO granted patent US12599480B2 to Edwards Lifesciences Corporation for a prosthetic heart valve designed for percutaneous mitral valve replacement. The device includes an outer frame with a main body and atrial flange, a cover, an inner frame, and a valve structure with leaflets. The atrial flange has an oval shape corresponding to the patient's native mitral valve anatomy.
Medical device manufacturers and investors should monitor patent publications to identify similar technologies in development and assess potential infringement risks. The patent provides Edwards Lifesciences with exclusive rights to the disclosed valve design for the term of the patent.
What to do next
- Monitor patent publications for similar technologies
- Review patent claims for potential overlap with existing products
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Percutaneous mitral valve replacement device
Grant US12599480B2 Kind: B2 Apr 14, 2026
Assignee
Edwards Lifesciences Corporation
Inventors
Travis Zenyo Oba, Seung-Beom Yi, Lauren R. Freschauf, Juan Valencia
Abstract
A prosthetic heart valve includes an outer frame, a cover, an inner frame, and a valve structure. The outer frame includes a main body and an atrial flange. The main body includes a plurality of struts forming a plurality of circumferential rows of cells, a plurality of rows of barbs extending from junctions of the struts, the atrial flange extending radially outwardly and in an atrial direction from the inflow end of the main body. The atrial flange includes an oval shape corresponding to a shape of the patient's native mitral valve anatomy. The cover is disposed on a radially inner side of the atrial flange and on a radially outer side of the atrial flange. The inner frame is disposed within the outer frame and has a cylindrical shape. The valve structure is coupled to the inner frame and includes a plurality of leaflets.
CPC Classifications
A61F 2/2418 A61F 2220/0016 A61F 2220/0075 A61F 2230/0034 A61F 2250/0097 A61F 2/2439 A61F 2/2436
Filing Date
2023-11-15
Application No.
18510534
Claims
10
Related changes
Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.